Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Today, we announced our investigational glucagon/GLP-1 dual receptor agonist achieved key measures of success at 48 weeks in our IMPACT Phase 2b trial and recent interactions with the FDA have resulted in alignment on the parameters for a registrational Phase 3 trial
Mounjaro (tirzepatide) injection [Prescribing information]
Skincare That Nurtures More Than Just Beauty Can confidence begin with your skin
40, Tirzepatide 15mg HbA1c -2.3%, HbA1c 1.9%
When prescribing GLP-1 medications for individuals with advanced kidney disease, extra care is essential to ensure both safety and effectiveness
US$ 24.96
US$ 28.67
US$ 23.76
US$ 21.51
